RGNX stock news
This page provides real-time market news, earnings updates, and company announcements related to REGENXBIO Inc. (RGNX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-06-27 06:04 EST
US Stocks Move: Regenxbio Plunges 32% Pre-market
格隆汇2026-01-28 12:53:38
What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?
Finviz2026-03-09 17:33:53
STEPHEN PAKOLA OVERSAW RGX-111 SAFETY CLAIMS THAT COST RGNX INVESTORS MILLIONS: SUEWALLST, LLP
Finviz2026-03-19 13:04:04
According to a document submitted to the U.S. Securities and Exchange Commission, biotechnology company Regenxbio Inc has confirmed that it will continue, under its existing sublicensing agreement with pharmaceutical giant GlaxoSmithKline, to pay the latter the relevant amounts received from sublicensees.
老虎证券2026-03-20 21:33:00
According to the latest filing from the U.S. Securities and Exchange Commission (SEC), biotechnology company Regenxbio Inc has officially signed a settlement and release agreement with pharmaceutical giant GlaxoSmithKline.
老虎证券2026-03-20 21:33:32
Regenxbio Inc recently announced that the company expects to hold a Type A meeting with the U.S. Food and Drug Administration (FDA) in July this year.
老虎证券2026-06-22 11:51:37
Regenxbio stated that it has reached a consensus with the U.S. Food and Drug Administration (FDA) on the next steps needed for potential accelerated approval of the gene therapy Naxsunli.
老虎证券2026-06-22 11:51:38
According to the latest filing from the U.S. Securities and Exchange Commission (SEC), biotechnology company Regenxbio Inc has officially signed a settlement and release agreement with pharmaceutical giant GlaxoSmithKline.
老虎证券2026-03-20 21:33:32
Regenxbio Inc recently announced that the company expects to hold a Type A meeting with the U.S. Food and Drug Administration (FDA) in July this year.
老虎证券2026-06-22 11:51:37
Regenxbio stated that it has reached a consensus with the U.S. Food and Drug Administration (FDA) on the next steps needed for potential accelerated approval of the gene therapy Naxsunli.
老虎证券2026-06-22 11:51:38
RGNX stock chart
RGNX stock detailsRGNX stock price change
On the last trading day, RGNX stock closed at 10.53 USD, with a price change of 2.83% for the day.
Trade spot stocks (24/7)Trade stock perps (up to 100x leverage)About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
To provide deeper liquidity, a more transparent trading experience, and greater capital efficiency, Bitget officially launched its all-new spot stock product, Bitget Stocks 2.0, on June 2, 2026.
The new product is independently issued by licensed RWA protocol Reality, with Bitget providing strategic support and asset security safeguards. This marks a major upgrade to the stock trading experience.
Bitget is moving stock trading beyond the limits of traditional trading models by fully integrating stock assets into its margin and yield ecosystem.
Learn more